Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | CASCA REMEDIES PVT LTD | 3 | ₹10,608 |
| 2 | Schedule 2 | SUPREME INTERNATIONAL PHARMACEUTICALS | 14 | ₹77,720 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
20 Mar 2026, 10:00 amClosed
TAPENTADOL 50 MG TAB
TELMISARTAN 20MG TAB
9094224
GEM/2026/B/7333210
Two Packet Bid
TAPENTADOL 50 MG TAB,TELMISARTAN 20MG TAB
Delhi; Central Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
10%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| TAPENTADOL 50 MG TAB | Central Delhi | 4,800 | 15 days | |
| TELMISARTAN 20MG TAB | Central Delhi | 268,000 | 15 days |
Exempted
Yes
20 Mar 2026
9 Mar 2026
20 Mar 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9094224.pdf
GEM_BID
compiled_echs_2025-26_-_line_item_creator_2026-03-09-09-53-34_a2236e6b84aa609db9ac52508afb120b.pdf
SPECIFICATION
compiled_echs_2025-26_-_line_item_creator_2026-03-09-09-55-31_4b864b39091afcb4a1f61f7bc399ebb0.pdf
SPECIFICATION
NEWATC_7ee68735-f583-4018-86a21773030674366_gauravsharma.207a@gov.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
compiled_echs_2025-26_-_line_item_creator_2026-03-09-09-53-34_a2236e6b84aa609db9ac52508afb120b.pdf
GEM_SPEC • 0.02 MB
compiled_echs_2025-26_-_line_item_creator_2026-03-09-09-55-31_4b864b39091afcb4a1f61f7bc399ebb0.pdf
GEM_SPEC • 0.02 MB
NEWATC_7ee68735-f583-4018-86a21773030674366_gauravsharma.207a@gov.in.pdf
GEM_OTHER • 1.82 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .